This Article Full Text Full Text (PDF) Other Versions of this Article: JVI.01571-06v1 81/1/272    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Abend, J. R. Articles by Imperiale, M. J. Search for Related Content PubMed PubMed Citation Articles by Abend, J. R. Articles by Imperiale, M. J.

Inhibitory Effect of Gamma Interferon on BK Virus Gene Expression and Replication

Johanna R. Abend, Jonathan A. Low, and Michael J. Imperiale^*

Department of Microbiology and Immunology and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, Michigan 48109

Received 21 July 2006/ Accepted 4 October 2006

BK virus (BKV) is widely accepted to be the causative agent of polyomavirus nephropathy. In immunocompromised individuals, especially kidney transplant recipients, BKV can replicate in kidney epithelial cells, causing loss of renal function and eventual destruction of the graft. Advances in immunosuppressive therapies may be partially responsible for the increasing incidence of polyomavirus nephropathy among transplant recipients by more effectively eliminating components of the immune system, such as gamma interferon (IFN-)-producing lymphocytes, that keep BKV infections at a subclinical level. In this study, we investigated the role of IFN- in regulating lytic infection by BKV. Treatment with IFN- inhibited the expression of the viral early protein large tumor antigen (TAg) and the late protein VP1 in a dose-dependent manner. We detected 1.6- and 12-fold reductions in TAg transcripts at 48 and 96 h postinfection, respectively, with 250 U/ml IFN-, suggesting that IFN--mediated inhibition occurs at the level of transcription. Furthermore, IFN- inhibited the level of viral progeny production as much as 50-fold at a multiplicity of infection (MOI) of 0.5 and 80-fold at an MOI of 0.1. The inhibitory effects of IFN- were similar for three different strains of BKV examined. These results indicate an important role for IFN- in regulating BKV lytic infection.

Published ahead of print on 11 October 2006.

Current address: Eli Lilly and Company, 355 East Merrill Street, Indianapolis, IN 46225.